The project "Targeted Quatsome nanocarriers for the delivery of microRNA for neuroblastoma therapy" (TAG-SMARTLY), coordinated by Nora Ventosa from the NANOMOL Group at the ICMAB-CSIC, has been selected for a https://www.ciber-bbn.es/convocatorias/convocatoria-de-proyectos-de-transferencia-y-valorizacion-del-ciber-bbn-2020" valorization program from CIBER-BBN, and will receive funding of 45,000 euros for the coming two years (2020-2022). The consortium is completed by another CIBER-BBN group led by Miriam Royo (IQAC-CSIC), and two external partners, led by Miguel F. Segura (Vall d'Hebron Research Institute, VHIR) and Santiago Sala (Nanomol Technologies S.L.), will contribute to the project.TAG-SMARTLY builds on a patented laboratory-scale proof of concept of a nanomedicine, which is based on Quatsome (QS) nanovesicles that deliver RNA molecules, such as microRNAs or siRNAs, to cancerous cells.The objective of the TAG-SMARTLY project is to advance in the pharmaceutical development of the nanomedicine platform, to complete the non-regulatory preclinical testing for the treatment of high-risk neuroblastoma, a highly aggressive pediatric tumor with scant therapeutic options.